Clear Impact logo

Vermont Medicaid/CHIP (CCS-21)

Logo

Budget Information

What We Do

Who We Serve

How We Impact

Measures

Time
Period
Current Actual Value
Current Target Value
Current
Trend
Baseline
% Change
CCS-21
ADD: Follow-Up Care for Children Prescribed ADHD Medication - Initiation* - Age 6-12 (CCS-21)
PM
2021
67.9%
2
2%
CCS-21
ADD: Follow-Up Care for Children Prescribed ADHD Medication - Continuation* - Age 6-12 (CCS-21)
PM
2021
73.3%
1
5%
CCS-21
AMB: Ambulatory Care - Emergency Department (ED) Visits - Age 0-19 yrs* (CCS-21)
PM
2021
24.2
1
-35%
CCS-21
AMR: Asthma Medication Ratio: Age 5–18 (CCS-21)
PM
2021
70.4%
1
1%
CCS-21
APM: Metabolic Monitoring for Children & Adolescents on Antipsycotics: Blood Glucose & Cholesterol - Age 1-17 (CCS-21)
PM
2021
27.6%
1
-19%
CCS-21
APP: Use of First Line Psychosocial Care of Child & Adolescents on Antipsychotics - Age 1-17 (CCS-21)
PM
2021
74.4%
2
5%
CCS-21
CCP: Contraceptive Care – Postpartum Women - MMEC 60 days- Age 15–20 (CCS-21)
PM
2020
34.4%
2
-14%
CCS-21
CCP: Contraceptive Care – Postpartum Women - LARC 60 days- Age 15–20 (CCS-21)
PM
2020
27.1%
2
-13%
CCS-21
CCW: Contraceptive Care - All Women - MMEC - Age 15-20 (CCS-21)
PM
2020
26.2%
1
1%
CCS-21
CCW: Contraceptive Care - All Women - LARC - Age 15-20 (CCS-21)
PM
2020
12.1%
1
7%
CCS-21
CHL: Chlamydia Screening in Women - Age 16-20 (CCS-21)
PM
2021
41.5%
2
-16%
CCS-21
CIS-DTaP: Childhood Immunization Status - Age 2 (CCS-21)
PM
2020
80.7%
85.5%
2
3%
CCS-21
CIS-MMR: Childhood Immunization Status - Age 2 (CCS-21)
PM
2020
89.1%
93.7%
1
2%
CCS-21
CIS-VZV (Chicken pox): Childhood Immunization Status - Age 2 (CCS-21)
PM
2020
86.0%
91.5%
1
4%
CCS-21
CIS-Flu: Childhood Immunization Status - Age 2 (CCS-21)
PM
2020
61.2%
65.2%
1
1%
CCS-21
DEV: Developmental Screening in the 1st 3 Years of Life - Total Rate* (CCS-21)
PM
2021
53.1%
1
55%
CCS-21
FUH: Follow-Up After Hospitalization for Mental Illness - 30 day - Age 6-20* (CCS-21)
PM
2020
88.1%
81.7%
2
6%
CCS-21
FUH: Follow-Up After Hospitalization for Mental Illness - 7 day - Age 6-20* (CCS-21)
PM
2020
68.4%
60.4%
1
0%
CCS-21
IMA: Immunization Status for Adolescents - Combo 1 Rate* - Age 13 (CCS-21)
PM
2020
72.9%
82.3%
2
25%
CCS-21
IMA: Immunization Status for Adolescents - Combo 2 Rate* - Age 13 (CCS-21)
PM
2020
29.1%
36.9%
3
88%
CCS-21
LBW: Live Births Weighing Less Than 2,500 Grams (CCS-21)
PM
2019
9.4%
1
25%
CCS-21
PDENT: % of Eligibles Who Received Preventive Dental Services - Age 1-20 (CCS-21
PM
CCS-21
PPC: Prenatal Care Rate (CCS-21)
PM
2021
84.7%
1
22%
CCS-21
SEAL: Dental Sealants for 6-9 Year Old Children at Elevated Caries Risk (CCS-21)
PM
2020
34.1%
1
-3%
CCS-21
W30: Well-Child Visits in the First 30 Months of Life: First 15 Months (CCS-21)
PM
2021
70.4%
0
0%
CCS-21
W30: Well-Child Visits in the First 30 Months of Life: 15-30 Months (CCS-21)
PM
2021
83.3%
0
0%
CCS-21
WCC: Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents: BMI - Age 3-17 (CCS-21)
PM
2021
61.8%
1
2%
CCS-21
WCC: Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents: Nutrition - Age 3-17 (CCS-21)
PM
2021
67.4%
1
8%
CCS-21
WCC: Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents: Physical Activity - Age 3-17 (CCS-21)
PM
2021
60.1%
1
3%
CCS-21
WCV: Child & Adolescent Well-Care Visits - Age 3-21 (CCS-21)
PM
2021
54.7%
0
0%

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy